If you would like to submit a proposal for an oral or poster presentation at this
meeting, please click the 'submit abstract' button to view the information required
for your submission.
When ready just return to this page and fill out the form accordingly.
All abstracts will be reviewed by the Scientific Advisory Board and applicants will
be notified of the result in due course.
Successful applicants will be provided with all necessary information.
Abstract Content:
- Written in English
- Written in the third person
- Include title, name(s) and affiliation(s) of the authors
- Between 100 - 200 words
- Suitable for direct publication in the proceedings pack and on the website
- Related to the subject of the conference
Agenda Topics- Biomarkers & Companion Diagnostics for Targeting Cancer Immunotherapy
- Checkpoint and Non-Checkpoint Immunotherapies
- Chimeric Antigen Receptor (CAR) T-Cells in Cancer Immunotherapy
- Clinical Trials and Commercialization of Cell Therapies
- Combination Cancer Immunotherapy
- ESC and iPSC-derived Cells for Cellular Therapy and Clinical Deployment
- Gene Therapy into the Clinic
- Clinical Pipeline
- Regulatory Landscape
- Technology Platforms
- Immunomodulatory Antibodies
- Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
- Small Molecules in Cancer Immunotherapy
- Stem Cells for Cellular Therapy
- Targeting Signaling Pathways in Cancer as Therapeutic Intervention
Copyrights
The presenting author/person who submitted the abstract assumes full responsibility
of the content of the abstract and we assume that all co-authors are aware of this
content. Please note that your biography, summary and abstract may be used on this
website and conference materials.
|
